Chief Business Officer (CBO)
May Tsai
Chief Business Officer (CBO) of
YD Biopharma
May Tsai is a highly experienced leader with over two decades of expertise in supply chain management, procurement, project management, and risk management. As the Chief Business Officer (CBO) at YD Biopharma, she brings a wealth of knowledge in driving business strategies, operational excellence, and enhancing stakeholder relationships to support the company’s growth and global expansion.
At YD Biopharma, we are dedicated to advancing the future of healthcare through innovation, operational efficiency, and strategic business development. Together, we are creating solutions that will transform the industry and improve lives.
Academic Excellence
Master of Business Administration, University of North Carolina, Charlotte (2008–2009)
Diploma in Business Mathematics, SooChow University (1989–1994)
Professional Achievements
Successfully leading procurement and supply chain teams to achieve cost savings, operational KPIs, and business goals.
Leading office relocation and renovation projects, enhancing workspaces and driving operational excellence.
Pioneering the implementation of end-to-end processes and SAP ERP systems to streamline procurement and improve forecasting accuracy.
Building strong relationships with key stakeholders, resulting in increased business satisfaction and improved project outcomes.
Professional Experience
Country Head of Procurement Taiwan & Hong Kong, Novartis Taiwan (2018–2023)
Head of Procurement TW & Asia Cluster, Novartis Taiwan (2014–2017)
Sourcing Head, Novartis Taiwan (2013–2014)
Logistics Manager, Novartis Taiwan (2006–2010)
Vision and Leadership
May Tsai’s leadership blends her strong background in procurement and project management with her ability to drive strategic initiatives and operational success. She is committed to expanding YD Biopharma’s presence globally, ensuring the company remains at the forefront of innovation and business excellence.
